| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |